Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Introducing a delicious and refreshing functional beverage that is not only tasty but also healthier than other options. This startup offers a unique drink that is both satisfying and beneficial for your well-being.

Saphlux, Inc. develops cutting-edge light-emitting materials for advanced LED, Micro-LED, and laser diode technology. Their semi-polar GaN products are revolutionizing the industry with superior performance and efficiency.

BEKhealth leverages its AI-driven chart abstraction and patient-matching platform to empower organizations conducting clinical trials and observational studies. This innovative solution enhances patient population insights, optimizes feasibility, accelerates site selection, and swiftly identifies clinically qualified candidates.

Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.

Ancera specializes in fast cell separation and pathogen diagnostics, revolutionizing biotech. Their cutting-edge technology streamlines processes for quicker results.

ProteoWise offers advanced technology with high information content, fast processing, and affordable pricing. It provides a unique solution for users seeking a powerful and cost-effective tool.

Omnicyte develops precise cancer therapies for targeted treatment, providing innovative solutions in biotechnology.

Propria enhances accessibility and strength of engineered heart tissue (EHT) for scientists, aiming to revolutionize cardiac research.

Clariti empowers ASCs, hospitals, and surgeons with a patient cost estimator and quote generator to navigate the evolving reimbursement landscape. This tool enhances cash flow, boosts pricing transparency and patient loyalty, streamlines operations, and ensures compliance in states with fa.

Advanced Office Systems offers small businesses access to high-tech solutions previously exclusive to larger companies. With Managed Network Services, clients can now afford cutting-edge technology to enhance their operations.

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

BEKhealth leverages its AI-driven chart abstraction and patient-matching platform to empower organizations conducting clinical trials and observational studies. This innovative solution enhances patient population insights, optimizes feasibility, accelerates site selection, and swiftly identifies clinically qualified candidates.

Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.

Advanced Office Systems offers small businesses access to high-tech solutions previously exclusive to larger companies. With Managed Network Services, clients can now afford cutting-edge technology to enhance their operations.

Saphlux, Inc. develops cutting-edge light-emitting materials for advanced LED, Micro-LED, and laser diode technology. Their semi-polar GaN products are revolutionizing the industry with superior performance and efficiency.

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Saphlux, Inc. develops cutting-edge light-emitting materials for advanced LED, Micro-LED, and laser diode technology. Their semi-polar GaN products are revolutionizing the industry with superior performance and efficiency.

Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.

Saphlux, Inc. develops cutting-edge light-emitting materials for advanced LED, Micro-LED, and laser diode technology. Their semi-polar GaN products are revolutionizing the industry with superior performance and efficiency.

Introducing a delicious and refreshing functional beverage that is not only tasty but also healthier than other options. This startup offers a unique drink that is both satisfying and beneficial for your well-being.

BEKhealth leverages its AI-driven chart abstraction and patient-matching platform to empower organizations conducting clinical trials and observational studies. This innovative solution enhances patient population insights, optimizes feasibility, accelerates site selection, and swiftly identifies clinically qualified candidates.

Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.

Clariti empowers ASCs, hospitals, and surgeons with a patient cost estimator and quote generator to navigate the evolving reimbursement landscape. This tool enhances cash flow, boosts pricing transparency and patient loyalty, streamlines operations, and ensures compliance in states with fa.

Introducing a delicious and refreshing functional beverage that is not only tasty but also healthier than other options. This startup offers a unique drink that is both satisfying and beneficial for your well-being.

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.